0.1985
price down icon17.29%   -0.0415
after-market Handel nachbörslich: .19 -0.0085 -4.28%
loading

Finanzdaten der Virpax Pharmaceuticals Inc-Aktie (VRPX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
29.50%
3.3025
4.6841 6.1151 3.2395 1.6511
Operating Income/Loss
29.50%
-3.3025
-4.6841 -6.1151 -3.2395 -1.6511
Nonoperating Income/Loss
0.082
- - - -
Income/Loss From Continuing Operations Before Tax
29.40%
-3.2204
-4.5617 -5.9945 -3.1128 -1.5205
Income/Loss From Continuing Operations After Tax
29.40%
-3.2204
-4.5617 -5.9945 -3.1128 -1.5205
Net Income/Loss
29.40%
-3.2204
-4.5617 -5.9945 -3.1128 -1.5205
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
111.11%
1.1712
-10.54 11.71 11.71 11.71
Diluted Average Shares
111.11%
1.1712
-10.54 11.71 11.71 11.71
Basic Earnings Per Share
77.20%
-2.75
-12.06 -0.51 -0.27 -0.13
Diluted Earnings Per Share
77.20%
-2.75
-12.06 -0.51 -0.27 -0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$76.29
price down icon 6.45%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
$19.13
price down icon 7.54%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Kapitalisierung:     |  Volumen (24h):